Form 8-K - Current report:
SEC Accession No. 0001808805-26-000027
Filing Date
2026-06-18
Accepted
2026-06-18 16:05:43
Documents
11
Period of Report
2026-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K naut-20260617.htm   iXBRL 8-K 49597
  Complete submission text file 0001808805-26-000027.txt   165333

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20260617.xsd EX-101.SCH 1785
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20260617_lab.xml EX-101.LAB 21615
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20260617_pre.xml EX-101.PRE 12510
14 EXTRACTED XBRL INSTANCE DOCUMENT naut-20260617_htm.xml XML 2727
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 261102520
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)